Peek Laura J, Martin Talia T, Elk Nation Charity, Pegram Shannel A, Middaugh C Russell
Department of Pharmaceutical Chemistry, University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA.
J Pharm Sci. 2007 Mar;96(3):547-57. doi: 10.1002/jps.20762.
Excipients for protein-based vaccines are currently identified by evaluating the stability of the protein in solution. In most cases, however, the protein is adsorbed to the surface of an aluminum salt adjuvant in the final vaccine formulation. Previous studies showed that model protein antigens may be structurally altered and less thermally stable upon adsorption to aluminum salt adjuvants [Jones LS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR, 2005, J Biol Chem 280:13406-13414]. The work presented herein provides evidence that compounds that stabilize the protein in solution also stabilize the adsorbed protein; however, the stability of the adsorbed protein in the presence of the stabilizer remains lower than that of the protein in solution. Potential implications of the reduced stability on the approach used to select excipients during formulation development are discussed.
基于蛋白质的疫苗辅料目前是通过评估蛋白质在溶液中的稳定性来确定的。然而,在大多数情况下,蛋白质在最终疫苗制剂中会吸附到铝盐佐剂的表面。先前的研究表明,模型蛋白抗原吸附到铝盐佐剂后可能会发生结构改变且热稳定性降低[Jones LS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR, 2005, J Biol Chem 280:13406-13414]。本文所呈现的工作提供了证据,表明在溶液中稳定蛋白质的化合物也能稳定吸附的蛋白质;然而,在稳定剂存在下吸附蛋白质的稳定性仍低于溶液中蛋白质的稳定性。文中讨论了稳定性降低对制剂开发过程中选择辅料的方法可能产生的影响。